“Father of Organ Transplantation” Dies

Thomas Starzl performed the first successful human liver transplant in 1967 and went on to help develop drugs that improved survival for organ transplant patients.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Thomas Starzl diesUNIVERSITY OF PITTSBURGHThomas Starzl, a surgeon who revolutionized the field of organ transplantation, died on Saturday (March 4) at his home in Pittsburgh at the age of 90. He performed the some of the very first liver transplants in the 1960s, including the first such surgery in which the patient lived more than one year after the operation. He also pioneered the use of various immunosuppressant drugs to help prevent organ rejection, now part of standard surgical procedure.

“We regard him as the father of transplantation,” Abhinav Humar, clinical director of the Thomas E. Starzl Transplantation Institute, told the Associated Press. “His legacy in transplantation is hard to put into words—it’s really immense.”

After earning an MD/PhD with a focus in neurophysiology from the Northwestern University Medical School in 1952, Starzl worked at Johns Hopkins Hospital in Baltimore, the University of Miami, and the Veterans Administration Research Hospital in Chicago, before joining the Northwestern faculty in 1958. In 1962, he moved to the University of Colorado School of Medicine, where he led the team of surgeons that performed the first successful liver transplant in a human patient in 1963. It would be another four years, however, until the team completed a transplant in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies